Focus on hereditary endocrine neoplasia

Slides:

Advertisements

Similar presentations

Lessons from Hereditary Colorectal Cancer

Advertisements

Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr

Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.

Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.

ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.

Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.

Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity Cai-Hong.

Modeling Inducible Human Tissue Neoplasia Identifies an Extracellular Matrix Interaction Network Involved in Cancer Progression Jason A. Reuter, Susana.

Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung Zvi Granot, Erik Henke, Elizabeth A. Comen, Tari A. King, Larry Norton, Robert Benezra.

Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)

Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.

A Conditional Mouse Model for Malignant Mesothelioma Johan Jongsma, Erwin van Montfort, Marc Vooijs, John Zevenhoven, Paul Krimpenfort, Martin van der.

A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin Malay Haldar, Jeffrey D. Hancock, Cheryl M. Coffin, Stephen L. Lessnick,

Tema: Etički problem: slučajno otkrivene patološke mutacije

Targeting HIF2α in Clear-Cell Renal Cell Carcinoma

Fig. 1. Serial changes of the Von Hippel Lindau (VHL) disease patient

Focus on lymphangiogenesis in tumor metastasis

Focus on endometrial and cervical cancer

Metastasis gets site specific

Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer

Management of advanced renal cancer

A Mitochondrial Power Play in Lymphoma

Three Down and One To Go: Modeling Medulloblastoma Subgroups

Multiple Effects of Angiopoietin-2 Blockade on Tumors

Killing Tumors by Keeping Ras and PI3′ Kinase Apart

Cell signaling and cancer

The linchpin? Pin1 meets p73

Volume 2, Issue 3, Pages (September 2002)

DAISY: Picking Synthetic Lethals from Cancer Genomes

Volume 26, Issue 1, Pages 1-2 (July 2014)

ABT-199: Taking Dead Aim at BCL-2

Fungating malignant phyllodes tumor

Pancreatic Cancer—Could It Be that Simple

A Radical Role for p38 MAPK in Tumor Initiation

Volume 4, Issue 1, Pages 4-6 (July 2003)

Volume 6, Issue 3, Pages (September 2004)

The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?

Targeting HIF2α in Clear-Cell Renal Cell Carcinoma

Focus on lymphangiogenesis in tumor metastasis

Microsatellite Instability in Benign Skin Lesions in Hereditary Non-Polyposis Colorectal Cancer Syndrome Victoria J. Swale, Anthony G. Quinn, Veronique.

Richard G. Carroll, Seamus J. Martin Cancer Cell

Importance of Surveillance for Multiple Endocrine Neoplasia-1 and Surgery in Patients With Sporadic Zollinger–Ellison Syndrome Maneesh H. Singh, Douglas.

Considering the critical interface between tumor cells and stromal cells in the search for targets for anticancer therapy Laurence Blavier, Yves A. DeClerck

Frances Balkwill, Kellie A. Charles, Alberto Mantovani Cancer Cell

An Integrin-Linked Machinery of Cytoskeletal Regulation that Enables Experimental Tumor Initiation and Metastatic Colonization Tsukasa Shibue, Mary W.

Antigen-Presenting Cells: Professionals and amateurs

Breaking News on Fragile Sites in Cancer

Volume 64, Issue 5, Pages (November 2003)

847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach Molecular.

Erik C. von Rosenvinge, MD, Stephen A. Wank, MD, Ramona M. Lim, MD

Bmi1 and Cell of Origin Determinants of Brain Tumor Phenotype

Multiple Effects of Angiopoietin-2 Blockade on Tumors

Volume 17, Issue 2, Pages (February 1950)

Volume 14, Issue 4, Pages (October 2008)

Volume 16, Issue 3, Pages (September 2009)

The Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Lung Cancer: Still Following the Right TRAIL? Emmet E. McGrath, MB, PhD Journal of Thoracic.

International Thymic Malignancies Interest Group: A Way Forward

A common pathway for genetic events leading to pheochromocytoma

To Infinium, and Beyond! Cancer Cell

Volume 10, Issue 3, Pages (September 2006)

Co-opted integrin signaling in ErbB2-induced mammary tumor progression

Volume 163, Issue 2, (October 2015)

There's a Time and a Place for MYCN

Volume 17, Issue 2, Pages (February 2010)

Ibrutinib Treatment of CLL: The Cancer Fights Back

Pharmacological Rescue of p53 in Cancer Therapy: Widening the Sensitive Tumor Spectrum by Targeting MDMX Jean-Christophe Marine Cancer Cell Volume.

Volume 12, Issue 6, Pages (December 2007)

The Ups and Downs of Src Regulation: Tumor Suppression by Cbp

A “Big Data” View of the Tumor “Immunome”

Presentation transcript:

Focus on hereditary endocrine neoplasia Allen M. Spiegel Cancer Cell Volume 6, Issue 4, Pages 327-332 (October 2004) DOI: 10.1016/j.ccr.2004.09.023

Figure 1 Major sites developing benign and/or malignant tumors in endocrine neoplasia syndromes Multiple endocrine neoplasia types 1 and 2 (MEN1 and MEN2, respectively), McCune-Albright syndrome (MAS), Carney complex (CNC), hyperparathyroidism-jaw tumor syndrome (HPT-JT), hereditary paranganglioma syndrome (PGL), and von Hippel-Lindau disease (VHL). Cancer Cell 2004 6, 327-332DOI: (10.1016/j.ccr.2004.09.023)